CUBE vs ETON · P/E 25, rev $1.07B vs rev $39.0M
CubeSmart (CUBE) versus Eton Pharmaceuticals Inc (ETON) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Eton Pharmaceuticals Inc (ETON) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported ETON revenue for 2024-12-31 was $39.0M. Net income was -$3.8M. Revenue was up 23.3% from 2023-12-31 to 2024-12-31. ETON currently screens at market cap $797.9M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. ETON currently screens at market cap $797.9M.
Not investment advice. Open the CUBE and ETON stock pages for the full models.
Not investment advice.